Description

The use of artificial intelligence (AI) is growing rapidly in the medical field, especially in diagnostics and management of treatment. AI in medical diagnosis helps with medical decision making, management, automation, admin, and workflows. According to StrategyHelix, the global ai in medical diagnostics market is expected to increase by US$ 1.82 billion during 2021-2027, expanding at a CAGR of 21.6% during the forecast period.

The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for ai in medical diagnostics. The global ai in medical diagnostics market is segmented on the basis of component, application, end user, and region. Based on component, the global ai in medical diagnostics market is categorized into hardware, software, and services. The software segment held the largest share of the global ai in medical diagnostics market in 2020 and is anticipated to hold its share during the forecast period. On the basis of application, the global ai in medical diagnostics market has been segmented into cardiology, neurology, oncology, orthopedics, and others. By end user, the global ai in medical diagnostics market has been segmented into hospitals & clinics, and diagnostic centers. Geographically, the global ai in medical diagnostics market is segmented into Asia Pacific, Europe, North America, and Rest of the World (RoW).

The global ai in medical diagnostics market is highly competitive. The leading players in the ai in medical diagnostics market include Canon Medical Systems Corporation, DeepMind Technologies Limited, F. Hoffmann-La Roche AG, FUJIFILM Corporation, GE Healthcare, Intel Corporation, International Business Machines Corporation, Koninklijke Philips N.V., Medtronic plc, Microsoft Corporation, Nvidia Corporation, Siemens Healthineers AG, Xilinx Inc.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the ai in medical diagnostics market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Component: hardware, software, and services
Application: cardiology, neurology, oncology, orthopedics, and others
End user: hospitals & clinics, and diagnostic centers
Region: Asia Pacific, Europe, North America, and Rest of the World (RoW)
Years considered: this report covers the period 2017 to 2027

Key Benefits for Stakeholders

– Get a comprehensive picture of the global ai in medical diagnostics market
– Pinpoint growth sectors and trends for investment

Table of Contents

1. Market definition
2. Research methodology
3. Market data and outlook
3.1 Market size estimates
3.2 Forecast
4. Ai in medical diagnostics market by component
4.1 Hardware
4.2 Software
4.3 Services
5. Ai in medical diagnostics market by application
5.1 Cardiology
5.2 Neurology
5.3 Oncology
5.4 Orthopedics
5.5 Others
6. Ai in medical diagnostics market by end user
6.1 Hospitals & clinics
6.2 Diagnostic centers
7. Ai in medical diagnostics market by region
7.1 Asia Pacific
7.2 Europe
7.3 North America
7.4 Rest of the World (RoW)
8. Company profiles
8.1 Canon Medical Systems Corporation
8.2 DeepMind Technologies Limited
8.3 F. Hoffmann-La Roche AG
8.4 FUJIFILM Corporation
8.5 GE Healthcare
8.6 Intel Corporation
8.7 International Business Machines Corporation
8.8 Koninklijke Philips N.V.
8.9 Medtronic plc
8.10 Microsoft Corporation
8.11 Nvidia Corporation
8.12 Siemens Healthineers AG
8.13 Xilinx, Inc.
9. Appendix
9.1 About StrategyHelix
9.2 Disclaimer